Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Single Data Point That Changed Everything

Editor’s Note: Earlier this week one of the junior gold stocks in the KRO Portfolio announced major news, sending share prices soaring over 300% since our buy price was met. If you’re a subscriber, please log in to the Member&CloseCurlyQ...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...

African Copper Project PEA Depicts 'One of the Largest Undeveloped Mines Worldwide'

The key points from this company's recently released study results and plan are presented in a BMO Capital Markets note. In a March 25 research report, analyst Andrew Mikitchook noted that Ivanhoe Mines Ltd.'s (IVN:TSX; IVPAF:OTCQX) newly released NI 43-101 technical ...

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...

The Mirage Called 'Modern Monetary Theory'

I was poring over the Federal Reserve minutes from Feb. 21, and as I was rolling my eyes and looking around my den for something to throw, I was reminded of the comments from then-Fed chairman Ben Bernanke years ago when he was asked if the Fed was "monetizing debt." The ...

Masochism and the Average Gold Investor

Masochism and the Average Gold Investor Source: Michael J. Ballanger for Streetwise Reports 04/22/2019 Sector expert Michael Ballanger discusses generational attitudes toward investing and how they are affecting the precious metals markets. Masochism: "...

The Charm of Fishing

As many of you know, I love to spend the summers exploring the thousands upon thousands of bays and inlets and coves that represent the Georgian Bay landscape. With the exception of a few boyhood jaunts around the Parry Sound area, I was not able to fully appreciate the g...

Malevolent Microbes

There is a local casino just "up the road" from where we reside that we visit (once in a blue moon), small sums of pocketed cash in hand, to play a few favored slot machines to see if we can defy the house odds and come home winners. Called The Great Blue Heron Casino, we...

Underowned and Underloved

Back in the Dark Ages, before cellular phones and the Internet, I was studying to complete the Ontario Securities course one afternoon when I came across the part discussing "asset allocation" and "portfolio construction." This section covered the recommended mix of bonds...
1 2 3 4 5 6 7 8 9 10 ...